Gender-specific methylation differences in relation to prenatal exposure to cigarette smoke

Abstract

Epigenetic alterations may mechanistically explain the developmental origins of adult disease, namely the hypothesis that many complex adult chronic diseases originate as a result of conditions encountered in utero. If true, epigenetically regulated imprinted genes, critical to normal growth and development, may partially mediate these outcomes. We determined the influence of in utero exposure to cigarette smoking on methylation at two differentially methylated regions (DMRs) regulating Insulin-like Growth Factor 2 (IGF2) and H19, and how this might relate to birth weight of infants born to 418 pregnant women. Smoking status was ascertained through self-report and medical records. Bisulfite pyrosequencing was used to measure methylation in umbilical cord blood DNAs. Least squares DNA methylation means at each DMR and birth weight were compared between infants of smokers and non-smokers, using generalized linear models. While there were no significant differences at the H19 DMR, infants born to smokers had higher methylation at the IGF2 DMR than those born to never smokers or those who quit during pregnancy (49.5%, SD = 8.0 versus 46.6%, SD = 5.6 and 45.8%, SD = 6.3, respectively; p = 0.0002). The smoking-related increase in methylation was most pronounced in male offspring (p for sex interaction = 0.03), for whom approximately 20% of smoking-related low birth weight was mediated by DNA methylation at the IGF2 DMR. Our findings suggest that IGF2 DMR plasticity is an important mechanism by which in utero adjustments to environmental toxicants are conferred. Larger studies to replicate these findings are required.

Introduction

Despite repeated demonstrations of adverse birth outcomes resulting from in utero exposure to cigarette smoking, the prevalence of smoking during pregnancy remains at around 14% in the United States (CDC, 2009). The mechanisms that link exposure to adverse outcomes are poorly understood but appear to be mediated by non-genotoxic adaptations to the gestational environment and/or exposure to toxicants (Barker, 1990, Gluckman et al., 2005). Epidemiologic evidence strongly supports links between conditions encountered during embryonic or fetal development and adult-onset diseases, including atherosclerosis, coronary heart disease, type 2 diabetes mellitus, obesity, and cancer [for review, see (Godfrey and Barker, 2001)].These chronic diseases and conditions have also been linked to low birth weight resulting from exposure to both active (Stillman et al., 1986) and passive cigarette smoking during pregnancy (Martin and Bracken, 1986).

Commonly studied non-genotoxic effects are epigenetic mechanisms, including modification of histone proteins and DNA methylation, which have also been hypothesized to explain how in utero exposure to cigarette smoking affects adult-onset diseases. However, the ability to test this hypothesis has been stymied due to the restricted type of biological specimens obtainable from otherwise healthy populations (e.g., peripheral blood, buccal cells) coupled with the lack of identified mitotically stable epigenetic targets that are not substantially influenced by inherent tissue specific differences in methylation.

DNA methylation, the most studied epigenetic mechanism in epidemiologic studies, is typically associated with chromatin condensation through the binding of methyl-CpG binding proteins and recruitment of proteins involved in chromatin modification that ultimately lead to transcriptional silencing (Portela and Esteller, 2010). DNA methylation regulates genomically imprinted genes through differential marking of the parental alleles during two epigenetic reprogramming events in early pregnancy; in gametogenesis, when methylation is erased and re-established to reflect the sex of the individual in which the developing gametes reside, and after fertilization, when the maternal and paternal pronuclei undergo demethylation and subsequent remethylation that will help guide germ layer specification and tissue differentiation (Feng et al., 2010, Kota and Feil, 2010). We have previously postulated that the mitotic stability of the methylation marks associated with imprinted genes coupled with establishment pre-gastrulation makes them especially suited for epidemiologic study of in utero environmental effects on the epigenome (Hoyo et al., 2009). The inherent plasticity of the epigenome during this period of epigenetic remodeling may allow for adaptive epigenetic profiles to be established at the sequences regulating imprinted genes, modifying gene expression patterns in response to perceived in utero environmental conditions.

The well-characterized imprinted domain at human chromosome 11p15.5 contains paternally expressed Insulin-like Growth Factor II (IGF2) and the maternally expressed H19 gene, from which is transcribed a non-coding RNA. Imprinted expression and transcription of IGF2 are regulated in large part through the patterns of DNA methylation of at least two differentially methylated regions (DMRs), one of which is located near the H19 promoter (H19 DMR) and the other upstream of the three IGF2 promoters that are subject to imprinting (IGF2 DMR). Both DMRs have been shown to exhibit altered methylation in cigarette smoking-related malignancies (Cruz-Correa et al., 2004, Cui et al., 2002). In the present study, we examined the influence of in utero exposure to cigarette smoke on DNA methylation at the IGF2/H19 imprinted domain using umbilical cord blood specimens naïve to the ex utero environment. We furthermore determined the extent to which methylation profiles mediate the link between maternal smoking and low birth weight.